ICU + Toxicology Flashcards

1
Q

Causes of distributive shock

A

Sepsis
SIRS
Anaphylaxis
Mitochondrial dysfunction (cyanide)
Endocrine crisis (thyroid, adrenal)
HLH
Post cardiac surgery vasoplegia
Liver failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Causes of cardiogenic shock

A

ACS
Arrhythmia
Acute valvulopathy
Right or left sided heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

causes of obstructive shock

A

PE
Tamponade
Tension pneumothorax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

causes of hypovolemic shock

A

Trauma
Hemorrhage
Burns
Operative losses
GI Losses
Renal Losses
Third spacing (pancreatitis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Definition of sepsis as per SCCM 2021

A

“Life threatening organ dysfunction secondary to dysregulated host response to infection”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Criteria for septic shock (SCCM 2021)

A

Septic Shock = Sepsis +
Despite adequate volume resuscitation, Persistent ↓BP requiring vasopressors to keep MAP ≥ 65
lactate > 2 mmol/L
(need both)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ScvO2 criteria for differentiating between cardiogenic and other forms of shock.

A

Drawn from IJ central line
Contains blood from SVC
Normal O2 level is 60-65%
>80% indicates a high flow rate such as sepsis
<65% indicates low flow rate such as cardiogenic or hypovolemic shock.
(numbers are as per IMR slides, different thresholds in different literature)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Immediate resuscitation guideline for Sepsis as per surviving sepsis 2021

A

30ml/kg of crystalloid in first 3 hours
Norepinephrine first line pressor for MAP<65 and no longer fluid responsive
Broad spectrum antibiotics within first hour
DO NOT MEASURE PROCALCITONIN TO HELP DECIDE WHETHER TO INITIATE ANTIBIOTICS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

SEPSIS antibiotic recommendation as per IMR slides

A

PIPTAZO follow by individual risk for:
MRSA (dialysis, known MRSA colonized, recurrent skin/soft tissue infection, Person Who Injects Drugs, central lines,)
- VANCO
MultiDrug resistant Organism (previous abx within 3 months, known MDR colonization, local prevalence, travel to endemic
country or hospitalization abroad):
- 2x ABx coverage (weak recommendation, low quality evidence)
Fungal (neutropenia, immunocompromised, TPN, dialysis, chronic lines, PWID, HIV, Heme or solid organ
transplant, emergency GI surgery or anastomotic leak)
-

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Dynamic variables for guiding fluid resuscitation in Sepsis
(surviving sepsis guideline 2021)

A
  1. Response to fluid bolus
  2. Passive leg raise (45% for 30-90 secs) inc. 15% in stroke volume = still fluid responsive.
  3. Pulse pressor variation > 10%
  4. ECHO
    - Stroke volume / variation
    - IVC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

IVC Interpretation on ECHO for fluid responsiveness

A

–Intubated, fully ventilated-Distensibility Index >15-20% likely to be fluid responsive
Intubated breathing spontaneously, cannot use
– Spontaneously breathing not intubated IVC <2cm and respiratory variation>50%, likely fluid responsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

IMR recommended dosing for Norepinephrine infusion

A

Norepinephrine
0.05-0.5mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

IMR Recommended dosing for Epinephrine infusion

A

Epinephrine
0.05-0.5mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

IMR recommended dosing for Vasopressin infusion

A

Vasopressin 2.4 units/hr

Add vasopressin when
Norepinephrine approx 0.25 –0.5 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

IMR recommended dosing for Dobutamine infusion

A

Dobutamine 2.5-10 mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IMR recommended dosing for milrinone infusion

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Physiological response to phenylephrine

A

HR: Dec.
SVR: Inc
CO: dec.
PcWP: Inc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Physiological response to Norepinephrine

A

HR: Inc.
SVR: Inc
CO: Inc/neut
PcWP: Inc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Physiological response to Epinephrine

A

HR: Inc
SVR: Inc
CO: Inc
PcWP: Dec.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Physiological response to Vasopressin

A

HR: Dec/ Neut
SVR: Inc
CO: Dec/ neut
PcWP: Inc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Physiological response to Dobutamine

A

HR: Inc
SVR: Dec
CO: Inc
PcWP: Dec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Physiological response to milrinone

A

HR: Inc/ Neut
SVR: Dec
CO: Inc
PcWP: Dec

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Physiological response to dopamine

A

HR: inc
SVR: inc
CO: inc
PcWP: Inc

Doesn’t cross BB barrier

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When to consider Steroids in Sepsis

A

Theory: may help immune dysregulation, relative adrenal insufficiency. “pressor sparing agent”
- Consider when Norepinephrine at 0.25 >4hours

Hydrocortisone 200mg/d (50mg IV q6H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Indications for high flow nasal canula
Hypoxemic respiratory failure Patients taking NIV breaks Post-op patients
26
When should High Flow Nasal Canula NOT be used
Post extubation if high risk of failure (NIV preferred) Acute hypercapnic respiratory failure
27
Physiological benefits of CPAP
reduced respiratory muscle oxygen consumption recruitment of alveoli improved V/Q matching Reduced LV afterload Reduced preload
28
Physiological benefits of BiPAP
reduced respiratory muscle oxygen consumption recruitment of alveoli improved V/Q matching Reduced LV afterload Reduced preload Increased Alveolar ventilation
29
indications for NIV
BiPAP mild-severe acidosis (rr >20-24, pH<7.35, PaCO2>45) Cardiogenic pulmonary edema
30
When should NIV NOT be used
treatment of post-extubation resp failure Hypercapnic with NO acidosis No recommendations for: Asthma Resp Failure NYD, Acute resp failure secondary to viral illness.
31
Contraindications to NIV
Facial surgery, trauma, airway obstruction Decreased LOC (includes worsening agitation when starting BiPAP) Inability to clear secretions Respiratory arrest Hemodynamic instability (reduces preload) Strong indications for intubation.
32
how to decrease PaCO2 on a ventilator
increase RR Increase Tidal volume (minute ventilation = RR*Tidal volume)
33
How to Increase SpO2 (PaO2) on a ventilator
increase FiO2 increase PEEP Increase Inspiratory time Affect O2 Delivery: Inc. CO, Inc Hb Dec. O2 consumption: treat fever, agitation stop pulmonary vasodilators (nitroprusside)
34
what is the Peak inspiratory pressure
reflects airway resistance + Lung compliance Target <35cm H2O
35
what is Plateau Pressure
The pressure in the lungs when no air is moving, reflects lung compliance This is the pressure that the alveoli are seeing target <30cm H20 May be confounded by chest wall restriction (IE Obesity)
36
What is Positive End Expiratory Pressure
Pressure at the end of the respiratory cycle Increases solubility of gas Splits airways, decreases work of breathing.
37
What is the driving Pressure
Pplat - PEEP (Target <15) OR Tidal Volume/ Static compliance
38
Sepsis treatment options specifically mentioned to NOT GIVE
IVIG Vitamin C Polymyxin Angiotensin II infusion Levosimendan Activated Protein C Liberal oxygen (target 94-96%, a sat >96% increases mortality in critically ill)
39
Criteria for Mild ARDS (2023 update)
Timing: within 1 week of known insult Pulmonary edema that is not attributable to Cardiogenic or fluid overload Bilateral infiltrates on CXR, CT or Ultrasound (by a trained professional) *P:F 201-300 with NIV/CPAP PEEP ≧ 5 or HFNC >30l/min SpO2:FiO2 <315 with SpO2 <97%
40
Criteria for moderate ARDS (2023 update)
Timing: within 1 week of known insult Pulmonary edema that is not attributable to Cardiogenic or fluid overload Bilateral infiltrates on CXR, CT or Ultrasound (by a trained professional) *P:F 101-200 with NIV/CPAP PEEP ≧ 5 or HFNC >30l/min SpO2:FiO2 <315 with SpO2 <97%
41
Criteria for severe ARDS (2023 update)
Timing: within 1 week of known insult Pulmonary edema that is not attributable to Cardiogenic or fluid overload Bilateral infiltrates on CXR, CT or Ultrasound (by a trained professional) *P:F <100 with NIV/CPAP PEEP ≧ 5 or HFNC >30l/min SpO2:FiO2 <315 with SpO2 <97%
42
Treatment for ARDS
1. ventilation strategies 2. Prone position 3. Neuromuscular blockade 4. ECLS/ECMO 5. Corticosteroids 6. Inhaled pulmonary vasodilator
43
Pathophysiology of ARDS
* Proteinaceous fluid fills alveoli * Neutrophils flood alveolar space * Hyaline membranes form on epithelial basement membrane * Microthrombi form * Fibrosis develops (late stage)
44
Causes of ARDS
Direct Lung Injury * Pneumonia * Aspiration pneumonitis * Drowning * Thoracic trauma/pulmonary contusion * Smoke or toxic inhalation * Fat emboli * Reperfusion injury (post lung transplant) Systemic inflammation * Severe sepsis * Transfusion reaction (TRALI) * Shock * Pancreatitis
45
Vent settings for ARDS
Mode: Volume Control Tidal volume (Vt): Initial Vt at 6ml/kg PBW à target 4-8 ml/kg PBW Plateau pressure: ≤ 30 cm H2O, Driving pressure (Pplat - PEEP) target < 15 cm H2O PEEP: target higher PEEP in mod/severe ARDS, based on FiO2-PEEP Tables SpO2: target 88-93% or PaO2 55 - 80 mmHg (avoid hyperoxia – ↑s harm) CO2: permissive hypercapnia allowed, target pH > 7.25 * Deep sedation to achieve the above parameters * Lung Recruitment Maneuvers: Don’t use routinely (evidence of ↑ mortality). Can be considered. * High frequency oscillation: Do not use
46
ARDS patients who should be Considered for ECMO
* Severe ARDS * Hypercapneic respiratory failure * Bridge to lung transplantation * Primary graft dysfunction after lung transplantation * Status asthmaticus
47
ARDs patients who should NOT be considered for ECMO
Absolute * Disseminated malignancy * Known severe brain injury * Prolonged CPR without adequate tissue perfusion * Severe chronic organ dysfunction * Severe chronic pulmonary hypertension * Non-recoverable advanced comorbidity (ie. CNS damage or terminal malignancy)
48
Criteria to consult for ECMO:
Call for ECMO referral if: * P/F < 80 mmHg for > 6 hours OR P/F < 50 mmHg for > 3 hours * PaCO2 > 60 mmHg for > 6 hours (despite optimization of vent) * Mechanically ventilated < 7 days * BMI < 40 or weight < 125 kg * Age 18 - 65
49
COVID Tx
50
SBT
Should occur daily
51
Assess readiness for weaning from ventilator 1. Reversal of underlying reason for intubation and ventilation 2. Improvement of oxygenation (PaO2 > 60 mmHg, FiO2 < 40%, PEEP < 8) 3.Ability to perform work of breathing (Normal/compensated Co2, pH, adequate cardiac function, adequate diaphragm function)
52
Assess readiness for extubation 1. Adequate cough 2. Minimal secretions, ability to manage secretions 3. Awake/Alert, following commands, no sedation 4. No increased risk of airway obstruction – post-op swelling resolved, ETT cuff leak present
53
Dexmetatomidine
* Alpha-2 agonist – acts on CNS receptors * Recent meta-analysis compared to Propofol and Benzodiazepines: – ↓risk of delirium (RR 0.67, 95% CI 0.55 to 0.81; moderate certainty) – ↓ duration of mechanical ventilation (MD - 1.8 h, 95% CI - 2.89 to - 0.71; low certainty) – ↓ ICU length of stay (MD - 0.32 days, 95% CI - 0.42 to - 0.22; low certainty) – Increased risk of bradycardia (RR 2.39, 95% CI 1.82 to 3.13; moderate certainty) and hypotension (RR 1.32, 95% CI 1.07 to 1.63; low certainty)
54
Haloperidol and Queiapine first line for delirium when at risk of hurting someone
55
Multimodal approach to pain management * Opioids are mainstay, especially post-op, but associated with side effects (respiratory depression, delirium, dependence) * Adjuncts should be used to reduce opioid requirements – Acetaminophen, NSAIDS (where appropriate) – Low dose ketamine (0.5 mg mg/kg bolus then 1-2 mcg/kg/min infusion) in post-operative patients – Gabapentin, pregabalin, carbamazepine for neuropathic pain – Do not routinely use lidocaine, local anesthetics or inhaled volatiles for pain adjuncts (may be effective for special circumstances – postoperative, trauma) * Others recommended: cold therapy, relaxation techniques, music, massage
56
neuroprognostication should wait at least 24 hours
57
3 pre-requisites before conducting DNC assessment 1. Mechanism causing devastating brain injury leading to death 2. Neuroimaging to support cause 3. Absence of confounders – Temperature: core ≥ 36 celsius (rectal, esophageal, bladder, arterial, bladder, central venous) – Time: wait ≥ 48hrs after arrest (unless imaging shows devastating injury) – Drugs: Wait 5 half lives if drug is known (e.g. sedatives, neuromuscular blockers, – Shock: Must be resuscitated appropriately (i.e. not un-resuscitated) – Metabolic disorders*: Na 125-159, PO4 >0.4, Glucose 3-30, pH 7.28-7.5, PaCO2 < 60, Urea < 40 (if available), Cr < 400, bilirubin < 100 “If these derangements cannot be corrected and are judged to be potentially contributing to the loss of brain function, ancillary investigation should be considered. ” – Severe weakness: myasthenia, ALS, spinal cord injury – Decompressive craniectomy
58
High lactate can be misinterpreted and ethylene glycol so if you see a very high lactate be suspicious of a toxic alcohol
59
Aspirin overdose antidote
Sodium bicarbonate
60
BB / CCB overdose antidote
High-Dose Euglycemic Insulin, glucagon, calcium, intralipid
61
Benzo Overdose Antidote
Flumazenil [caution – lasts up to an hour and if multiple drug ingestions or withdrawal seizure will make managing seizures a challenge!]
62
Cyanide poisoning antidote
Hydroxycobalamin, sodium thiosulfate,
63
Iron overdose antidote
Deferoxamine
64
Isoniazide toxicity antidote
Pyridoxine
65
Digoxin toxicity antidote
Digibind An IgG Anti digoxin antibody. These fragments bind free digoxin, thereby forming digoxin-immune fragment complexes. As the level of free digoxin in plasma falls, the resulting concentration gradient facilitates dissociation of digoxin from the sodium-potassium ATPase. Fab fragment complexes are renally excreted.